CD4+ T cells are the major predictor of HCMV control in allogeneic stem cell transplant recipients on letermovir prophylaxis

by Chris David Lauruschkat, Ihsan Muchsin, Alice Rein, Florian Erhard, Denise Grathwohl, Lars Dölken, Lars Dölken, Carolin Köchel, Christine Susanne Falk, Christine Susanne Falk, Christine Susanne Falk, Hermann Einsele, Sebastian Wurster, Götz Ulrich Grigoleit, Götz Ulrich Grigoleit, Sabrina Kraus
Published 2023-05-01